Girl Dies as Pluristem Sells on Gains With Miracle CellsDavid Wainer
Pluristem Therapeutics Inc.’s stock doubled in Nasdaq trading from May through September, helped by three news releases announcing that patients’ lives had been saved by injections of the company’s experimental stem cells.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- Gulf of Mexico Oil Spill May Be Largest Since 2010 BP Disaster
- Billionaire Tom Barrack Throws Harvey Weinstein a Lifeline
- Everything Is Crazy and the Markets Aren’t Freaking Out
- Facebook Is Looking for Employees With National Security Clearances
- Airbus Snaps Up Bombardier Jet in New Challenge to Boeing